The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Share
More article options
Full text access
What are the benefits and risks of calcimimetic agents in the management of secondary hyperparathyroidism in chronic renal failure?
¿Cuáles son los beneficios y peligros de los calcimiméticos en el tratamiento del hiperparatiroidismo secundario en la insuficiencia renal crónica?
Visits
4079
F. Rivera
This item has received
Article information




